|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0019409,
umls-concept:C0027651,
umls-concept:C0205314,
umls-concept:C0376358,
umls-concept:C0679622,
umls-concept:C1441547,
umls-concept:C1513403,
umls-concept:C1522642,
umls-concept:C1548328,
umls-concept:C1553412,
umls-concept:C1704387
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-24
|
|
pubmed:abstractText |
We recently described a new hormone refractory prostate cancer cell line, CL1, derived from LNCaP via in vitro androgen deprivation. To study gene expression during prostate cancer progression and to identify molecular targets for therapy, a pure clonal tumor system was generated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
299-307
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12712409-Animals,
pubmed-meshheading:12712409-Antineoplastic Agents,
pubmed-meshheading:12712409-Clone Cells,
pubmed-meshheading:12712409-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:12712409-Green Fluorescent Proteins,
pubmed-meshheading:12712409-Histocytochemistry,
pubmed-meshheading:12712409-Humans,
pubmed-meshheading:12712409-Luminescent Proteins,
pubmed-meshheading:12712409-Male,
pubmed-meshheading:12712409-Mice,
pubmed-meshheading:12712409-Mice, SCID,
pubmed-meshheading:12712409-Neoplasms, Hormone-Dependent,
pubmed-meshheading:12712409-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:12712409-Prostatic Neoplasms,
pubmed-meshheading:12712409-RNA, Neoplasm,
pubmed-meshheading:12712409-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12712409-Transfection,
pubmed-meshheading:12712409-Tumor Cells, Cultured,
pubmed-meshheading:12712409-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
|
|
pubmed:affiliation |
Department of Urology, UCLA, Los Angeles, California 90095-1738, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
